What are Live attenuated influenza vaccine drugs?

Live attenuated influenza vaccine drugs are pharmacologic agents that share a common mechanism. 2 are currently marketed, with 4 more in clinical development.

What are the marketed Live attenuated influenza vaccine drugs?

Marketed Live attenuated influenza vaccine drugs include FluMist trivalent (2015-2016), Intranasal Influenza Live Attenuated Vaccine.

Live attenuated influenza vaccine

2 marketed 3 in Phase 3 1 in Phase 2

This page covers all Live attenuated influenza vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Marketed (2)

FluMist trivalent (2015-2016) · MedImmune LLC · Immunology
FluMist is a live attenuated influenza vaccine that stimulates immune response by delivering weakened flu virus strains intranasally.
Intranasal Influenza Live Attenuated Vaccine · Jiangsu Province Centers for Disease Control and Prevention · Immunology
This live attenuated influenza vaccine stimulates immune responses by delivering weakened influenza virus strains intranasally to induce mucosal and systemic immunity.

Phase 3 pipeline (3)

CAIV-T, Liquid · MedImmune LLC · Immunology
CAIV-T is a live attenuated influenza vaccine administered as a nasal spray that stimulates mucosal and systemic immune responses against influenza.
CAIVT · MedImmune LLC · Immunology / Infectious Disease
CAIVT is a live attenuated influenza vaccine designed to provide broad protection against multiple influenza virus strains through intranasal delivery.
CAIV-T · MedImmune LLC · Immunology / Infectious Disease
CAIV-T is a live attenuated influenza vaccine administered intranasally that stimulates mucosal and systemic immune responses against influenza A and B viruses.

Phase 2 pipeline (1)

FluMist, Influenza Virus Vaccine Live · MedImmune LLC · Immunology
FluMist is a live attenuated influenza vaccine that replicates in the nasal mucosa to stimulate local and systemic immune responses against influenza viruses.